Leland W. Chung, MD

Board of Governors Chair in Cancer Research

Director, Uro-Oncology Research Program in the Samuel Oschin Comprehensive Cancer Institute

Professor, Medicine

Leland W. Chung, PhD

Phone:

310-423-5992

Leland W. Chung, PhD

Board of Governors Chair in Cancer Research

Director, Uro-Oncology Research Program in the Samuel Oschin Comprehensive Cancer Institute

Professor, Medicine

The research work of Leland Chung, PhD, focuses on reciprocal tumor-stroma interaction, molecular imaging and targeting.

  • Hu P, Chu GC, Zhu G, Yang H, Luthringer D, Prins G, Habib F, Wang Y, Wang R, Chung LW, et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS One. 2011;6(12):e28670.
  • Huang WC, Zhau HE, Chung LW. Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells. J Biol Chem. 2010 Mar 12;285(11):7947-7956.
  • Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, Zayzafoon M, Weizmann MN, Gururajan M, Chung LW. β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res. 2011 Apr 1;71(7):2600-2610.

English

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.